TechNavio's analysts forecast the Global Biosimulation market to grow at a CAGR of 18.31 percent over the period 2013-2018. One of the key factors contributing to this market growth is the reduction in drug discovery and development costs, owing to the deployment of biosimulation solutions. The Global Biosimulation market has also been witnessing increasing collaborations and partnerships. However, issues associated with the accuracy in prediction, could pose a challenge to the growth of this market.... Research Beam Model: Research Beam Product ID: 17304 2500 USD New
Global Biosimulation Market 2014-2018
 

Global Biosimulation Market 2014-2018

Global Biosimulation Market 2014-2018

Category : Materials & Chemicals
Published On : November  2013
Pages : 62

request-discount


TOLL FREE
+1-971-202-1575
------------ Or -------------
help@researchbeam.com

TechNavio's analysts forecast the Global Biosimulation market to grow at a CAGR of 18.31 percent over the period 2013-2018. One of the key factors contributing to this market growth is the reduction in drug discovery and development costs, owing to the deployment of biosimulation solutions. The Global Biosimulation market has also been witnessing increasing collaborations and partnerships. However, issues associated with the accuracy in prediction, could pose a challenge to the growth of this market. 
TechNavio's report, the Global Biosimulation Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers North America, Europe, the APAC region, and the ROW; it also covers the Global Biosimulation market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
The key vendors dominating this market space are Accelrys Inc., Certara L.P., Schrodinger Llc. and Simulation Plus Inc.
Other vendors mentioned in the report are Advanced Chemistry Development Inc., Archimedes Inc., Bayer Technology Services, Biomed Simulation Inc., Chemical Computing Group Inc., Compugen Ltd., Entelos Inc., Genedata AG, Immunetrix Inc., InhibOx Ltd., INOSIM Software GmbH, In Silico Biosciences Inc., Insilico Biotechnology AG, LeadInvent Technologies Pvt. Ltd., Leadscope Inc., Molecular Knowledge Systems Inc., Nimbus Discovery Llc, OpenEye Scientific Software Inc., Optimata Inc., Physiomics Plc, Rhenovia Pharma SAS, Synergix Ltd., and Vascular Sciences.
Key questions answered in this report: 
What will the market size be in 2018 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

 

 

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report


03.1 Market Overview

03.2 Product Offerings

04. Market Research Methodology

04.1 Market Research Process

04.2 Research Methodology

05. Introduction

06. Market Landscape


06.1 Market Overview

06.2 Market Size and Forecast

06.3 Five Forces Analysis

07. Market Segmentation by Application

08. Market Segmentation by Approach to Model Development

09. Market Segmentation by Scale of Biosimulation

10. Geographical Segmentation


10.1 Global Biosimulation Market Segmentation by Geography 2013-2018

10.2 Biosimulation Market in North America

10.2.1 Market Size and Forecast

10.3 Biosimulation Market in Europe

10.3.1 Market Size and Overview

10.4 Biosimulation Market in APAC

10.4.1 Market Size and Overview

10.5 Biosimulation Market in ROW

10.5.1 Market Size and Overview

11. Buying Criteria

12. Market Growth Drivers

13. Drivers and their Impact

14. Market Challenges

15. Impact of Drivers and Challenges

16. Market Trends

17. Trends and their Impact

18. Vendor Landscape


18.1 Competitive Scenario

18.1.1 Key News

18.2 Key Vendor Ranking 2013

18.3 Other Prominent Vendors

19. Key Vendor Analysis

19.1 Accelrys Inc.

19.1.1 Business Overview

19.1.2 Business Segmentation

19.1.3 Key Information

19.1.4 Sales by Region

19.1.5 SWOT Analysis

19.2 Certara L.P.

19.2.1 Business Overview

19.2.2 Business Segmentation

19.2.3 Key Information

19.2.5 SWOT Analysis

19.3 Schrodinger Llc

19.3.1 Business Overview

19.3.2 Business Segmentation

19.3.3 Key Information

19.3.4 SWOT Analysis

19.4 Simulation Plus Inc.

19.4.1 Business Overview

19.4.2 Business Segmentation

19.4.3 Key Information

19.4.4 Sales by Region

19.4.5 SWOT Analysis

20. Other Reports in this Series



List of Exhibits

Exhibit 1: Market Research Methodology

Exhibit 2: Market Segmentation

Exhibit 3: Market Segmentation by Application

Exhibit 4: Market Segmentation by Geography

Exhibit 5: Global Biosimulation Market 2013-2018 (US$ billion)

Exhibit 6: Global Biosimulation Market Segmentation by Application

Exhibit 7: Global Biosimulation Market Segmentation by Application 2013

Exhibit 8: Global Biosimulation Market Segmentation by Approach to Model Development

Exhibit 9: Global Biosimulation Market Segmentation by Scale of Biosimulation

Exhibit 10: Global Biosimulation Market Segmentation by Geography 2013

Exhibit 11: Global Biosimulation Market Segmentation by Geography 2013-2018 (percent)

Exhibit 12: Biosimulation Market in North America 2013-2018 (US$ million)

Exhibit 13: Biosimulation Market in Europe 2013-2018 (US$ million)

Exhibit 14: Biosimulation Market in APAC 2013-2018 (US$ million)

Exhibit 15: Biosimulation Market in ROW 2013-2018 (US$ million)

Exhibit 16: Business Segmentation of Accelrys Inc.

Exhibit 17: Sales by  Region of Accelrys Inc. 2012

Exhibit 18: Business Segmentation of Certara L.P.

Exhibit 19: Business Segmentation of Schrodinger Llc

Exhibit 20: Business Segmentation of Simulation Plus Inc.

Exhibit 21: Sales by Region of Simulation Plus Inc. 2012



 



Enquiry Before Buy